Tiziana Life Sciences Ltd
TLSA1.720USD
+0.060+3.64%
시장 운영 시간 （ET）시세는 15분 지연됩니다
191.77M시가총액
--P/E TTM
자세한 내용은 Tiziana Life Sciences Ltd 회사
Tiziana Life Sciences Ltd. is a United Kingdom-based clinical-stage biotechnology company that is specialized in the developing transformative therapies for neurodegenerative and neuroinflammatory. The Company’s clinical pipeline includes drug assets for secondary progressive multiple sclerosis, Alzheimer’s, and ALS. Its lead immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer’s and other CNS indications. Its Anti IL-6R mAb (TZLS-501), a fully human mAb binds to both membrane-bound and soluble forms of IL-6R, an inflammatory cytokine driving chronic inflammation associated with autoimmune disease and cancer, reducing circulating levels of the IL-6 cytokine.
회사 정보
종목 코드 TLSA
회사 이름Tiziana Life Sciences Ltd
상장일Nov 20, 2018
CEOMr. Ivor Elrifi
직원 수- -
유형Ordinary Share
회계 연도 종료Nov 20
주소3rd Floor, 11-12 St. James's Square
도시LONDON
증권 거래소NASDAQ Capital Market Consolidated
국가United Kingdom
우편 번호SW1Y 4LB
전화442074952379
웹사이트https://www.tizianalifesciences.com/
종목 코드 TLSA
상장일Nov 20, 2018
CEOMr. Ivor Elrifi
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Willy Jules Simon
Mr. Willy Jules Simon
Non-Executive Independent Director
Non-Executive Independent Director
8.25K
--
Mr. John P. Brancaccio, CPA
Mr. John P. Brancaccio, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Gabriele Marco Antonio Cerrone
Mr. Gabriele Marco Antonio Cerrone
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ivor Elrifi
Mr. Ivor Elrifi
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Ms. Keeren Shah
Ms. Keeren Shah
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. William A. Clementi, Pharm.D.
Dr. William A. Clementi, Pharm.D.
Chief Development Officer
Chief Development Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Willy Jules Simon
Mr. Willy Jules Simon
Non-Executive Independent Director
Non-Executive Independent Director
8.25K
--
Mr. John P. Brancaccio, CPA
Mr. John P. Brancaccio, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Gabriele Marco Antonio Cerrone
Mr. Gabriele Marco Antonio Cerrone
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ivor Elrifi
Mr. Ivor Elrifi
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Ms. Keeren Shah
Ms. Keeren Shah
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. William A. Clementi, Pharm.D.
Dr. William A. Clementi, Pharm.D.
Chief Development Officer
Chief Development Officer
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, Aug 16
마지막 업데이트: Sat, Aug 16
주주
주주 유형
주주
주주
비율
Cerrone (Gabriele M)
37.71%
Chernett (Jorey)
5.34%
Dauntless Investment Group, LLC
3.07%
Citadel Advisors LLC
0.18%
HSBC Global Asset Management (UK) Limited
0.09%
기타
53.61%
주주
주주
비율
Cerrone (Gabriele M)
37.71%
Chernett (Jorey)
5.34%
Dauntless Investment Group, LLC
3.07%
Citadel Advisors LLC
0.18%
HSBC Global Asset Management (UK) Limited
0.09%
기타
53.61%
주주 유형
주주
비율
Individual Investor
43.06%
Investment Advisor
3.56%
Investment Advisor/Hedge Fund
0.28%
Hedge Fund
0.19%
Research Firm
0.11%
기타
52.80%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
68
51.10M
45.84%
+9.72M
2025Q1
69
45.10M
40.46%
+3.34M
2024Q4
64
40.33M
36.45%
-5.07M
2024Q3
58
41.30M
37.43%
-3.04M
2024Q2
51
40.27M
36.45%
-4.04M
2024Q1
48
40.16M
36.35%
-4.27M
2023Q4
52
45.25M
44.24%
+1.19M
2023Q3
58
45.24M
44.24%
+1.10M
2023Q2
54
45.32M
44.32%
+1.19M
2023Q1
53
45.06M
44.06%
+868.09K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Cerrone (Gabriele M)
42.04M
37.71%
+2.70M
+6.85%
Mar 31, 2025
Chernett (Jorey)
5.95M
5.34%
+5.95M
--
Jun 11, 2025
Dauntless Investment Group, LLC
1.74M
1.56%
+1.74M
--
Mar 31, 2025
HSBC Global Asset Management (UK) Limited
105.36K
0.09%
--
--
Mar 31, 2025
Zhang Financial LLC
96.26K
0.09%
+3.07K
+3.30%
Mar 31, 2025
Susquehanna International Group, LLP
57.33K
0.05%
+57.33K
--
Mar 31, 2025
HRT Financial LP
70.37K
0.06%
+70.37K
--
Mar 31, 2025
Kovitz Investment Group Partners, LLC
79.36K
0.07%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
77.89K
0.07%
-167.84K
-68.30%
Mar 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Oct 20, 2021
Merger
2→1
Oct 20, 2021
Merger
2→1
Oct 20, 2021
Merger
2→1
Oct 20, 2021
Merger
2→1
Jul 16, 2020
Split
1→2.5
날짜
유형
비율
Oct 20, 2021
Merger
2→1
Oct 20, 2021
Merger
2→1
Oct 20, 2021
Merger
2→1
Oct 20, 2021
Merger
2→1
Jul 16, 2020
Split
1→2.5
